Lineage 2-Beijing Mycobacterium tuberculosis strains suppress BCG-trained innate immunity early after infection

This study demonstrates that Lineage 2-Beijing *Mycobacterium tuberculosis* strains evade BCG-induced trained innate immunity by suppressing key macrophage activation pathways, leading to impaired bacterial control both in vitro and in human contacts.

The Gist

The Big Picture: A "Hacker" vs. A "Security System"

Imagine your body is a high-tech castle, and Tuberculosis (TB) is a group of burglars trying to break in. For decades, we've had a "security system" called the BCG vaccine. It doesn't stop the burglars from entering, but it trains the castle guards (your immune cells) to recognize the enemy and fight back harder and faster if they get inside.

However, this new study found that the burglars have evolved. There is a specific, super-virulent type of TB (called Lineage 2-Beijing, or L2-B) that has learned how to hack the security system. Even though the guards are trained and ready, this specific type of burglar can sneak in, turn off the lights, and disable the alarms before the guards know what's happening.

The Cast of Characters

• The Guards (Alveolar Macrophages): These are the immune cells living in your lungs. Think of them as the castle's patrol officers.
• The Training (BCG Vaccine): This is the boot camp that teaches the patrol officers how to be "super guards" (trained immunity). They learn to spot the enemy and kill them quickly.
• The Burglars (M. tuberculosis):
  • Type L4: The "standard" burglars. They are tough, but if the guards are trained, the guards usually win.
  • Type L2-B (The Beijing Strain): The "elite hackers." They are highly contagious and have a special toolkit to bypass the trained guards.

What the Scientists Discovered

The researchers set up a simulation using mice to see what happens when these different burglars attack a castle with trained guards.

1. The Guards Get Tricked

In mice that had the BCG vaccine, the "super guards" (specifically a type called CD11bhi macrophages) were the first to fight the intruders.

• Against Type L4: The super guards did their job perfectly. They grabbed the burglars and crushed them.
• Against Type L2-B: The super guards grabbed the burglars, but the burglars didn't die. Instead, the L2-B strain seemed to say, "Nice try," and kept growing inside the guards. The vaccine-trained guards were completely ineffective against this specific strain.

2. The "Blackout" Strategy (The Molecular Hack)

The scientists looked inside the lungs to see how the L2-B strain was winning. They found that L2-B doesn't just fight; it rewires the castle's electrical grid.

• Turning off the Lights: The L2-B strain suppresses the genes (the instruction manuals) that tell the guards how to make weapons (antimicrobial proteins) and how to digest the enemy.
• Disabling the Battery: The guards need energy (metabolism) to fight. L2-B shuts down the power plants (metabolic pathways like glycolysis) that the guards need to stay active.
• The "Memory" Eraser: This is the most fascinating part. The BCG vaccine works by changing the "software" of the guards' DNA (epigenetics) to keep them on high alert. The L2-B strain specifically targets a piece of DNA called H3f3a (a histone variant).
  • Analogy: Imagine the vaccine writes a "Wanted" poster on the wall of the guard station. The L2-B strain doesn't just ignore the poster; it uses a solvent to erase the ink from the wall. It removes the "memory" of the training, leaving the guards confused and unprepared, even though they are still standing there.

3. It Happens in Humans Too

The researchers didn't just stop at mice. They looked at real people in Indonesia who had been exposed to TB in their homes.

• People exposed to the L2-B strain showed the same "erased memory" and "turned-off lights" in their blood tests, even before they officially tested positive for the infection.
• People exposed to the L4 strain showed a strong, active immune response.
• The Scary Part: The people who eventually got sick (converted to positive) showed these "hacked" signs very early, while they still thought they were healthy. The infection had already started disabling their defenses before the body even realized it was under attack.

Why This Matters

This study explains why the BCG vaccine works well in some parts of the world but fails in others. In areas where the L2-B "hacker" strain is common (like parts of Asia and increasingly globally), the vaccine's training is being neutralized.

The Takeaway:
We can't just keep making the same security system (BCG) and hoping it works. We need new strategies that:

1. Protect the "Memory": Create vaccines that are harder to erase (more resistant to the L2-B hack).
2. Boost the Power: Give the guards extra batteries so they can fight even if the burglar tries to cut the power.
3. Catch the Hack Early: Since the "hacking" happens so fast, we might need to test people's blood immediately after exposure to see if their immune system is being disabled, allowing us to treat them before they get sick.

In short, the TB bacteria have found a way to "un-train" our immune system, and we need to figure out how to lock that door before the burglars get in.

Technical Summary

1. Problem Statement

Despite widespread administration, the Bacille Calmette-Guérin (BCG) vaccine offers variable protection against Mycobacterium tuberculosis (Mtb), particularly against the modern Lineage 2-Beijing (L2-B) clade. Epidemiological data suggests L2-B strains evade BCG-induced immunity more effectively than non-Beijing strains (e.g., Lineage 4). While BCG is known to induce trained immunity (epigenetic and metabolic reprogramming of innate immune cells like macrophages), the specific mechanisms by which L2-B strains circumvent this trained state in the lung—the primary site of infection—remain unclear. This study aims to identify the lineage-specific evasion strategies employed by L2-B to subvert BCG-mediated protection during the early stages of infection.

2. Methodology

The study employed a multi-modal approach combining murine infection models, spatial transcriptomics, and human cohort analysis:

• Murine Model:

  • Vaccination: C57BL/6 mice were vaccinated intranasally with BCG Pasteur.
  • Challenge: Six weeks post-vaccination, mice were challenged via aerosol with fluorescently labeled clinical isolates of L2-B or Lineage 4 (L4) Mtb.
  • Cell Sorting & Functional Assays: Alveolar macrophages (AMs) were sorted into CD11b^hi and CD11b^lo subsets. A Mycobacterial Growth Inhibition Assay (MGIA) was performed ex vivo to quantify bacterial growth restriction (CFU) by these subsets.
  • Spatial Transcriptomics: Lung tissues were collected at Day 7 post-infection. Formalin-fixed, paraffin-embedded (FFPE) sections were analyzed using 10x Genomics Visium to map gene expression and cell-cell interactions within the tissue architecture.
  • Bioinformatics: Analysis included unbiased clustering (FlowSOM), differential gene expression (DESeq2), pathway enrichment (KEGG, GO), and transcriptional regulatory network inference (GENIE3, CellChat).

• Human Cohort (INFECT Study):

  • Population: 1,347 household contacts of sputum smear-positive TB patients in Indonesia.
  • Stratification: Contacts were exposed to index cases infected with either L2 or L4 strains (determined by Whole Genome Sequencing).
  • Outcome: Contacts were monitored for IGRA conversion (indicating new infection) over 3 months.
  • Transcriptomics: Whole blood RNA sequencing was performed on baseline samples (IGRA-negative) from contacts exposed to L2-B vs. L4, and specifically comparing those who later converted vs. those who cleared the infection ("early clearers").

3. Key Contributions

• Identification of the Primary Target: Demonstrated that CD11b^hi alveolar macrophages are the dominant infected cell population in BCG-vaccinated lungs and are the primary mediators of early bacterial control.
• Mechanism of Evasion: Uncovered that L2-B strains specifically suppress trained innate immunity pathways (metabolic, epigenetic, and antimicrobial) that are upregulated by BCG, a mechanism not observed with L4 strains.
• Epigenetic Disruption: Identified a novel, vaccine-specific evasion strategy where L2-B suppresses the histone variant H3f3a (H3.3) and its chaperone Asf1a, disrupting the chromatin accessibility required for trained immunity.
• Cross-Species Validation: Validated that the transcriptional signatures of immune suppression observed in mice are recapitulated in the peripheral blood of humans exposed to L2-B, even before systemic immune conversion (IGRA positivity).

4. Key Results

A. Functional Impairment of Trained Macrophages

• In BCG-vaccinated mice, CD11b^hi AMs (expanded by mucosal BCG) effectively restricted L4 growth but failed to control L2-B growth in ex vivo MGIA.
• Unvaccinated mice showed neutrophil-dominated infection, whereas vaccinated mice showed AM-dominated infection, highlighting the shift in immune architecture induced by BCG.

B. Spatial Transcriptomics: Suppression of Innate Programs

• Global Downregulation: L2-B infection in vaccinated lungs caused widespread downregulation of genes essential for macrophage activation, phagolysosome function, and antimicrobial killing (e.g., Cxcr3, Gbp8, Ifitm1/2, Clec4e, Cd63).
• Metabolic & Epigenetic Collapse: L2-B suppressed metabolic regulators (Hif1a, Hk2, Lamtor complex) and chromatin remodelers (Hdac1-3, Kmt5b, Setd1a).
• The H3f3a Finding: Crucially, the histone variant H3f3a (critical for maintaining open chromatin at inflammatory enhancers in trained cells) was markedly reduced in L2-B-infected vaccinated lungs, but not in unvaccinated mice or L4-infected lungs. This suggests L2-B actively dismantles the epigenetic infrastructure of trained immunity.
• Upregulation of Immunosuppression: L2-B infection upregulated immunoregulatory genes like Cd274 (PD-L1) and Ccl22, and increased B-cell interactions.

C. Transcriptional Regulatory Networks

• TF Rewiring: L2-B infection reduced the regulatory strength of TFs essential for trained immunity (e.g., CHD1, MAFB, IRF8, TRAF6) while upregulating stress-response TFs (BATF, DDIT3).
• Maladaptive Signaling: Specific TFs (e.g., STAT1, IRF1) retained regulatory influence but were linked to distinct, non-protective gene networks in L2-B infections, suggesting a hijacking of host signaling toward immune evasion.

D. Human Cohort Findings

• Higher Infection Risk: Household contacts exposed to L2-B strains had higher rates of IGRA conversion compared to those exposed to L4.
• Early Transcriptomic Signatures: Even in IGRA-negative contacts, baseline blood RNA-seq revealed that exposure to L2-B was associated with the suppression of innate immune pathways (chemokine signaling, TLR signaling, phagocytosis) and activation of oxidative phosphorylation and antibody production pathways.
• Predictive Value: These transcriptional defects were present before IGRA conversion, suggesting that failure of protective immunity is programmed very early after exposure.
• Concordance: The suppression of innate pathways and upregulation of B-cell/immunoglobulin signatures in human converters mirrored the findings in L2-B-infected vaccinated mice.

5. Significance

• Mechanistic Insight into Vaccine Failure: The study provides a molecular explanation for why BCG fails against L2-B strains: L2-B does not just resist killing; it actively disarms the epigenetic and metabolic programs established by BCG training.
• Target Identification: The specific suppression of H3f3a and metabolic regulators (HIF-1α, glycolysis) identifies critical vulnerabilities in the host that L2-B exploits.
• Translational Implications:
  • Vaccine Design: Future vaccines must not only induce activation but also preserve the metabolic and epigenetic infrastructure (e.g., via mTOR/HIF-1α pathways or β-glucan priming) to resist L2-B suppression.
  • Early Intervention: The discovery of early transcriptional signatures in human blood suggests that peripheral blood sampling could serve as a prognostic tool to identify individuals at high risk of infection failure, allowing for pre-emptive therapeutic intervention.
  • Strain-Specific Efficacy: The findings argue that new TB vaccines must be tested against diverse Mtb lineages, as a vaccine effective against L4 may be rendered ineffective by L2-B's specific evasion mechanisms.

In summary, the paper demonstrates that L2-B Mtb employs a sophisticated, lineage-specific strategy to erase the "memory" of trained immunity induced by BCG, primarily by disrupting histone variant supply and metabolic reprogramming, a mechanism that is conserved across mouse and human models.